Cytek Biosciences (CTKB) vs Mettler-Toledo International (MTD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Mettler-Toledo International (MTD) has outperformed Cytek Biosciences (CTKB) over the past year, gaining 14.8% versus a gain of 4.1%. Over five years, MTD leads with a +11.4% price change compared with -67.8% for CTKB. Mettler-Toledo International is the larger company by market cap ($33.15 billion vs $800.4 million), about 41.4 times the size.
On valuation, Mettler-Toledo International trades at a lower forward P/E (31.3x vs 87.4x for Cytek Biosciences). Mettler-Toledo International converts more of its revenue into profit, with a net margin of 21.6% versus -33.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTKB | MTD |
|---|---|---|
| Share price | $6.12 | $1,666.88 |
| Market cap | $800.40M | $33.15B |
| 1-day change | -3.16% | -2.27% |
| YTD return | +21.19% | +19.56% |
| 1-year return | +4.08% | +14.77% |
| 5-year return | -67.82% | +11.37% |
| P/E ratio (TTM) | — | 36.18 |
| Forward P/E | 87.43 | 31.32 |
| EPS (TTM) | $-0.63 | $46.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $201.49M | $4.03B |
| Revenue growth (YoY) | +0.52% | +3.98% |
| Net income (latest FY) | $-66.54M | $869.19M |
| Gross margin | 51.84% | 59.37% |
| Operating margin | -20.04% | — |
| Net margin | -33.02% | 21.59% |
| 52-week high | $6.39 | $1,806.58 |
| 52-week low | $3.31 | $1,023.05 |
| Distance from 52-week high | -4.15% | -7.73% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +6.21% | +4.24% |
| Average volume | 1.31M | 192.63K |
| Shares outstanding | 130.78M | 19.89M |
| Employees | 703 | 16,600 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Mettler-Toledo International is about 41.4 times larger than Cytek Biosciences by market value ($33.15B vs $800.40M).
- MTD has outperformed CTKB by 10.7 percentage points over the past year.
- Mettler-Toledo International is more profitable, keeping 21.6 cents of every revenue dollar as net income versus -33.0 cents for Cytek Biosciences.
About Cytek Biosciences
CTKB stock →Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 703 employees
About Mettler-Toledo International
MTD stock →Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 16,600 employees
CTKB vs MTD FAQ
Which is bigger, Cytek Biosciences or Mettler-Toledo International?
Mettler-Toledo International (MTD) is larger, with a market capitalization of $33.15B compared with $800.40M for Cytek Biosciences (CTKB).
Which stock has performed better over the past year, CTKB or MTD?
MTD returned +14.77% over the past 12 months, compared with +4.08% for CTKB (price return, excluding dividends). Past performance does not predict future results.
Are Cytek Biosciences and Mettler-Toledo International in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.